Search Results - "de Ridder, Mischa"

Refine Results
  1. 1

    Anaplastic thyroid carcinoma: a nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decades by de Ridder, Mischa, Nieveen van Dijkum, Els, Engelsman, Anton, Kapiteijn, Ellen, Klümpen, Heinz-Josef, Rasch, Coen R N

    Published in European journal of endocrinology (01-08-2020)
    “…Objective To perform a nationwide population based study in ATC on incidence, treatment and survival. Design Retrospective cohort study. Methods All patients…”
    Get full text
    Journal Article
  2. 2

    Long-Term Quality of Life of Vestibular Schwannoma Patients: A Longitudinal Analysis by Neve, Olaf M., Jansen, Jeroen C., Koot, Radboud W., Ridder, Mischa de, Paul G. van Benthem, Peter, Stiggelbout, Anne M., Hensen, Erik F.

    Published in Otolaryngology-head and neck surgery (01-02-2023)
    “…Objective Vestibular schwannoma management aims to maintain optimal quality of life (QoL) while preventing severe sequelae of the tumor or its treatment. This…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Target Definition in MR-Guided Adaptive Radiotherapy for Head and Neck Cancer by Ridder, Mischa de, Raaijmakers, Cornelis P J, Pameijer, Frank A, Bree, Remco de, Reinders, Floris C J, Doornaert, Patricia A H, Terhaard, Chris H J, Philippens, Marielle E P

    Published in Cancers (20-06-2022)
    “…In recent years, MRI-guided radiotherapy (MRgRT) has taken an increasingly important position in image-guided radiotherapy (IGRT). Magnetic resonance imaging…”
    Get full text
    Journal Article
  7. 7

    Prognostic value of pretreatment radiological MRI variables and dynamic contrast-enhanced MRI on radiotherapy treatment outcome in laryngeal and hypopharyngeal tumors by Smits, Hilde J.G., Vink, Saskia J., de Ridder, Mischa, Philippens, Marielle E.P., Dankbaar, Jan W.

    “…•The prognostic value of pre-radiotherapy DCE-MRI was analyzed in head and neck cancer.•The area under the contrast concentration curve of 60 s (AUC60) was…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Individual elective lymph node irradiation for the reduction of complications in head and neck cancer patients (iNode): A phase-I feasibility trial protocol by Reinders, Floris C.J., de Ridder, Mischa, Doornaert, Patricia A.H., P.J. Raaijmakers, Cornelis, Philippens, Marielle E.P.

    “…•In this study we will explore individual elective lymph node irradiation for HNC patients.•This new concept utilizes the MR-linac for imaging of individual…”
    Get full text
    Journal Article
  11. 11
  12. 12

    MRI visibility and displacement of elective lymph nodes during radiotherapy in head and neck cancer patients by Reinders, Floris C J, Stijnman, Peter R S, de Ridder, Mischa, Doornaert, Patricia A H, Raaijmakers, Cornelis P J, Philippens, Marielle E P

    Published in Frontiers in radiology (03-11-2022)
    “…To decrease the impact of radiotherapy to healthy tissues in the head and neck region, we propose to restrict the elective neck irradiation to elective lymph…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Head and Neck Paraganglioma by de Bresser, Carolijn J. M, van Nesselrooij, Bernadette P. M, van Treijen, Mark J. C, Braat, Arthur J. A. T, de Ridder, Mischa, Stokroos, Robert J, de Bree, Remco, de Borst, Gert J, Rijken, Johannes A, Petri, Bart-Jeroen

    Published in PloS one (25-07-2024)
    “…Introduction There is a lack of comprehensive and uniform data on head and neck paragangliomas (HNPGLs), and research is challenging due to its rarity and the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    BioXmark® liquid fiducial markers for image-guided radiotherapy in muscle invasive bladder cancer: a safety and performance trial by de Ridder, Mischa, Gerbrandy, Lara C, de Reijke, Theo M, Hinnen, Karel A, Hulshof, Maarten C C M

    Published in British journal of radiology (01-07-2020)
    “…This study evaluated the performance of the novel liquid fiducial marker (BioXmark®) in IGRT for bladder cancer. 20 patients with muscle invasive bladder…”
    Get full text
    Journal Article